Clinical Massively Parallel Sequencing.
The newest advances in DNA sequencing are based on technologies that perform massively parallel sequencing (MPS). Since 2006, the output from MPS platforms has increased from 20Mb to 7 Tb. First-generation MPS platforms amplify individual DNA molecules to multiple copies and then interrogate the seq...
| Publicado en: | Clinical Chemistry Vol. 66; no. 1; pp. 77 - 89 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
Oxford University Press / USA
Jan2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |